Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBMI in Beta Thalassemia Major
NCT04092205Phase 2Completed
- Sponsor
- EmeraMed
- Start
- Nov 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emeramide in iron overload, sponsored by EmeraMed. Started Nov 2019; status: completed.
02
Drugs
emeramide
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT04092205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04092205.